John Allen

Associate Dean for Diversity, Inclusion, and Health Equity | Clinical Associate Professor

University of Florida

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

John Allen serves as the Associate Dean for Diversity, Inclusion, and Health Equity and Clinical Associate Professor at the University of Florida, USA. His research primarily focuses on health equity, cancer risk associated with pharmacotherapy, and systemic disparities in medication use among diverse populations. Recent articles authored by him explore the implications of glucagon-like peptide-1 receptor agonists, the training of new researchers in health equity, and the importance of clinical pharmacy services in addressing structural factors affecting medication access.

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (18)

Lanting Yang

University of Pittsburgh

UNITED STATES

John Allen

Research Interests

Explore related searches

Contact this professor

About

Articles (24)

Structural factors and their influence on the use of novel antidiabetic agents: Making the case for increased awareness and access to clinical pharmacy services

Racial Disparities in Analgesic and Psychiatric Medication Use During End-Of-Life Care in Advanced-Stage Colorectal Cancer: A Retrospective Cohort Study

Tiered Training and Licensure for the Future of the Pharmacy Profession: Panacea or Pandora's Box?

Association of Glucagon-Like Peptide-1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes.

GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity.

A fair machine learning model to predict flares of systemic lupus erythematosus.

Training the Next Generation of Researchers to Advance Cancer Health Equity: Five Years of Experience from the Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center

Implementation and evaluation of a stop the bleed program at a college of pharmacy

Regional trends and disparities in newer GLP1 receptor agonist initiation among real-world adult patients eligible for obesity treatment.

A change to the pathway: The Impact of the Supreme Court of the United States affirmative action decision on clinical pharmacy and a call to action for pharmacists

Geographic variation and racial disparities in adoption of newer glucose-lowering drugs with cardiovascular benefits among US Medicare beneficiaries with type 2 diabetes.

Evaluation of Potential Racial Disparities in CYP2C19‐Guided P2Y12 Inhibitor Prescribing After Percutaneous Coronary Intervention

Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans

Implementing innovative teaching strategies to promote student academic engagement in a critical care elective

Impact of Piperacillin-Tazobactam Dosing in Septic Shock Patients Using Real-World Evidence: An Observational, Retrospective Cohort Study

Curricular changes in times of crisis: Lessons learned

Abstract A026: Disparities in the use of pain medication in patients with pancreatic cancer: Focus on racial and ethnic minorities

Abstract A027: Evaluation of psychotropic medication usage patterns in patients with pancreatic cancer by race/ethnicity

Abstract C026: Pharmacogenetics of pancreatic ductal adenocarcinoma: A review of racial disparities

Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies

Clinical pharmacists addressing social determinants of health needs and eliminating health disparities: Bystander or change agent?

Community Champions: The Crucial Contribution of an Independent Pharmacy in COVID-19 Vaccination Efforts in an Underserved Community

A scoping review on the relationship between race/ethnicity and the receipt of supportive care medications during cancer treatment: Implications for the clinical pharmacist

Pharmacoequity and the clinical pharmacist: Why not us, why not now!

Collaborators (18)

Lanting Yang

Nancy Borja‐Hart

Craig Lee

Sony Tuteja

Philip Empey

Lisa Scarton

Diana J. Wilkie

Jingchuan Guo

James Lee

Thomas J George

Julio Duarte

Sherise Rogers

Mary Bridgeman

Lauren Adkins

Jiang Bian

David DeRemer

Steven M. Smith

Larisa Cavallari

Make your next move.